title: [Case of malignant pheochromocytoma with successful control of systemic metastasis with CVD chemotherapy].
authors.forename: T
authors.initials: T
authors.lastname: Minami
authors.forename: Y
authors.initials: Y
authors.lastname: Doi
authors.forename: H
authors.initials: H
authors.lastname: Tetsuo
authors.forename: K
authors.initials: K
authors.lastname: Baba
authors.forename: S
authors.initials: S
authors.lastname: Seto
authors.forename: S
authors.initials: S
authors.lastname: Suzuki
authors.forename: M
authors.initials: M
authors.lastname: Hayano
authors.forename: S
authors.initials: S
authors.lastname: Yano
authors.forename: K
authors.initials: K
authors.lastname: Minami
authors.forename: E
authors.initials: E
authors.lastname: Oshibuchi
mesh_terms: D000310:Adrenal Gland Neoplasms / Q000473:pathology* / Q000601:surgery; D000315:Adrenalectomy; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001859:Bone Neoplasms / Q000188:drug therapy* / Q000556:secondary*; D003520:Cyclophosphamide / Q000008:administration & dosage; D003606:Dacarbazine / Q000008:administration & dosage; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy* / Q000556:secondary*; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000556:secondary*; D008297:Male; D008875:Middle Aged; D010673:Pheochromocytoma / Q000188:drug therapy* / Q000473:pathology / Q000556:secondary*; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D014750:Vincristine; D003606:Dacarbazine; D003520:Cyclophosphamide